Member Bibliography/Bibliografía de Miembros
This page collects all the personal publications that CienciaPR members have uploaded to their profiles. You can also see all of the authors collected in these publications or all the keywords contained in these publications.
] “Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.”, Clin Cancer Res, 2014.
“Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway.”, PLoS One, vol. 9, no. 5, p. e97094, 2014.
“Assessment of mRNA splice variants by qRT-PCR.”, Methods Mol Biol, vol. 1049, pp. 171-86, 2013.
“ATP11B mediates platinum resistance in ovarian cancer.”, J Clin Invest, vol. 123, no. 5, pp. 2119-30, 2013.
“Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes.”, Pharmaceuticals (Basel), vol. 6, no. 11, pp. 1361-80, 2013.
“Src activation by β-adrenoreceptors is a key switch for tumour metastasis.”, Nat Commun, vol. 4, p. 1403, 2013.
“Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.”, Gastroenterology, vol. 141, no. 5, pp. 1728-37, 2011.
“Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.”, PLoS One, vol. 6, no. 7, p. e21121, 2011.
“Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.”, J Natl Cancer Inst, vol. 103, no. 21, pp. 1596-612, 2011.
“Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.”, Clin Cancer Res, vol. 17, no. 11, pp. 3716-26, 2011.
“Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.”, Clin Cancer Res, vol. 17, no. 8, pp. 2250-9, 2011.
“Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.”, J Clin Invest, vol. 120, no. 5, pp. 1515-23, 2010.
“c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.”, Clin Cancer Res, vol. 16, no. 1, pp. 184-94, 2010.
“Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma.”, Mol Cancer Ther, vol. 9, no. 8, pp. 2377-88, 2010.
“SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer.”, Cancer Cell, vol. 18, no. 2, pp. 109-21, 2010.
“Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.”, J Biol Chem, vol. 285, no. 46, pp. 35462-70, 2010.
“Sustained small interfering RNA delivery by mesoporous silicon particles.”, Cancer Res, vol. 70, no. 9, pp. 3687-96, 2010.
“The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment.”, PLoS One, vol. 4, no. 10, p. e7502, 2009.
“Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.”, Int J Cancer, vol. 125, no. 2, pp. 264-75, 2009.
“Dual targeting of EphA2 and FAK in ovarian carcinoma.”, Cancer Biol Ther, vol. 8, no. 11, pp. 1027-34, 2009.
“Therapeutic Targeting of ATP7B in Ovarian Carcinoma.”, Clin Cancer Res, vol. 15, no. 11, pp. 3770-80, 2009.
“Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.”, Cancer Res, vol. 68, no. 14, pp. 5849-58, 2008.
“Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.”, Apoptosis, vol. 13, no. 7, pp. 915-28, 2008.
“MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.”, Br J Pharmacol, vol. 155, no. 7, pp. 1104-16, 2008.
“Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.”, Clin Cancer Res, vol. 14, no. 24, pp. 8143-51, 2008.
